Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Surmoruine is an over-the-counter (OTC) protective ointment developed and marketed by Eumedica. It is primarily indicated for the treatment and prevention of skin irritations, such as diaper rash (erythema) in infants and superficial burns. The formulation combines the skin-protecting properties of **zinc oxide** with the emollient and vitamin-rich properties of **cod liver oil**. Zinc oxide acts as a physical barrier against moisture and external irritants while providing mild astringent effects. Cod liver oil serves as a source of vitamins A and D, which are essential for promoting epithelialization and tissue repair. By forming a protective layer on the skin, Surmoruine soothes inflammation and supports the natural healing process of the epidermis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Surmoruine.